Monthly Archives: November 2011

Radiology: Polycystic liver

The polycystic liver can be as dramatic in person as it is on film.  While most cases are subtle, with multiple, small lobular lesions, some (as in the case shown here) have near obliteration of viable hepatic parenchyma.  Whatever is left, … Continue reading

Posted in Radiology | 1 Comment

Lecture: AASLD Review (Part 2/2)

Today we discussed additional topics from the recent AASLD conference in San Francisco.  First, there was the category of liver transplantation.  We learned that the IL28B polymorphism cannot reliably predict HCV recurrence in the transplant population, which is contrary to earlier … Continue reading

Posted in Lecture | Leave a comment

Monthly Conference Calendar: DECEMBER

All Lectures and Journal Clubs will be held at 2:30 PM in the East campus pathology conference room; they will follow the weekly 1:30 hepatopathology conference. Monday, Dec. 5: Chris Pappas, MD, JD; Baylor College of Medicine, Houston, TX Topic: … Continue reading

Posted in Pathology | Leave a comment

The Sunday Chronicles

“Oh you mean this Naproxen pen?  I..I’m I’m holding it for a friend.”  

Posted in The Sunday Chronicles | Leave a comment

Definition: culture negative neutracitic ascites

Culture negative neutracitic ascites (CNNA) is a diagnosis made when ascitic analysis reveals a neutrophil count > 250 but there is no bacterial growth in the culture medium.  Since this scenario represents most “positive” paracenteses, it is a more common diagnosis than spontaneous bacterial … Continue reading

Posted in Definition | Leave a comment

Clinical Pearl

Limiting protein intake in the cirrhotic patient with a history of hepatic encephalopathy is not really a great idea; it’s more or less an old wive’s tale (akin to not giving acetaminophen to the liver patient).  These patients need as much … Continue reading

Posted in Clinical Pearl | Leave a comment

Clinical Pearl

Palmar erythema (PE) always seems to be associated with portal hypertension. Did you realize how many other conditions are associated with PE? Pregnancy (30%), rheumatoid arthritis (60%), thyrotoxicosis (18%), diabetes mellitus (4%), use of amiodarone, gemfibrozil, topiramate, albuterol or cholestyramine, … Continue reading

Posted in Clinical Pearl | Leave a comment